FDA Import Refusal F23-9339962-1/140002/1 — Abbvie Biotechnology Gmbh
The FDA refused shipment F23-9339962-1/140002/1 from Abbvie Biotechnology Gmbh (Germany) on Sep 3, 2025. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 3, 2025
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY09 RISANKIZUMAB-RZAA
- Charges
- 75